跳至主要内容
临床试验/NCT02342132
NCT02342132已完成不适用

A Comparison of Three Methods for Improving Expiratory Cough Flow and Lung Volume in Children With Neuromuscular Diseases

University of British Columbia2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Muscle Strength

研究概览

简要总结

Children with neuromuscular diseases (NMDs) and weak chest muscles suffer frequent chest infections, hospital admissions and reduced life expectancy. Physiotherapy is widely used but there is limited research data to support choice of therapy. The investigators will study the clinical value of the three most commonly used chest physiotherapy devices in children with NMD's by measuring lung function tests before and after each of the three treatments. This is a pilot study. The best device will be selected for a long term study of early physiotherapy intervention in children with NMDs.

The treatments that have been developed to break the cycle of decreasing lung volume and poor secretion clearance, in children with NMDs, are all based on the same logical but unproved theory of treatment:

  1. The loss of lung volume is reversed by applying positive pressure to the lungs via a face mask - literally reinflating the lungs with pressure. The three devices the investigators will test all provide positive pressure assistance during the inspiratory phase.
  2. The temporarily increased lung volume then allows higher expiratory flow rates which helps to clear secretions. The expiratory phase is assisted by manual chest compression or, in one device, helped by application of negative pressure during exhalation.

All three devices that the investigators wish to compare follow this two-step approach. The hypotheses behind our study are:

  1. Treatments combining positive pressure inhalation with assisted coughing during exhalation, will produce measurable improvements in lung volume and expiratory cough flow rates when tested in children with NMDs.
  2. One of the three devices tested will be superior to the others. This will provide research-based justification for a long term study of the value of early intervention in children with NMDs.

详细描述

Current options for respiratory care in children with NMDs include numerous devices and treatments have been proposed for improving secretion clearance and lung function in very weak patients. Unfortunately treatment decisions are still based on little more than personal opinion. In particular, there are almost no carefully conducted studies on the best forms of respiratory therapy in children with NMDs. Commonly used treatment options are best listed under the following headings:

  1. Chest physiotherapy. This broad term covers a range of therapies that includes postural drainage, manual percussion and chest vibrations. These treatments are often preceded by inhaled medications intended to mobilize secretions (humidification, hypertonic saline, Dornase alpha). Chest physiotherapy has been studied extensively in cystic fibrosis(13) but there are no prospective studies of its use in children with NMDs. The lack of any evidence of clear long-term benefit combined with the need for a trained assistant, has limited the application of chest therapy to in-patient treatment of acute exacerbations.
  2. Breath stacking. Inspiratory lung volume can be increased by 'stacking' repeated inhalations. This allows a greater cough flow with improved secretion clearance. The simplest method is to use a bag, face mask and a one-way valve. Inspiratory volume can also be augmented using mechanical or non-invasive ventilators although care must be taken to avoid over-inflation and barotrauma(14). The cough phase after insufflation is often augmented by external compression of chest or abdomen (manually assisted cough). While there is evidence that breath stacking, with or without manually assisted coughing, can increase lung volume and peak cough flows(15), there are no prospective studies to study long term effects.
  3. Mechanical insufflation-exsufflation. Devices in this group inflate the lung with an inspiratory positive pressure phase followed rapidly by a negative pressure exhalation phase(16). They are widely used and recommended but prospective research support is lacking. As with breath stacking, there is evidence of short term improvement in lung volume and cough flows(17) following MI-E treatment. There are also retrospective reviews to suggest that the technique is effective and well tolerated in children(18). However, there are no prospective controlled studies of MI-E either in adults or children.
  4. Airway oscillation. Various devices have been developed to superimpose an oscillatory wave flow over normal breathing. The oscillating pressure wave is intended to help mobilise secretions and expand atelectatic areas of the lung. This can be achieved by an external vibrating vest or delivered directly to the airway through a face mask. Prospective study of the vibrating vest showed that it had no benefit(19). However, research exists that oscillation via mask is beneficial both in short(20) and longer term studies(21).

The newcomer to this important topic would be forgiven for finding the lack of research evidence difficult to believe. Children with NMDs are very complex management problems and they consume a lot of hospital resources. The mechanical devices paid for by insurance companies, or governments, cost many thousands of dollars each - surely all this money and time should be based on some form of evidence? Unfortunately this is not the case. Two large reviews of the management of NMDs by both the British(2) and the American(22) thoracic societies emphasized this lack of evidence. Both concluded that the major requirement in the management of these children is research.

The principal question in the management of children with NMDs is whether early introduction of effective respiratory therapy will slow the decline in lung function and help to keep these children out of hospital. That requires long term studies of the use of therapies known to be effective, at least in the short term. Such evidence - even short term evidence of efficacy, is not available. Our study is not a case of comparing a new treatment to an established therapy, it is a case of assessing current widely used treatments in order to determine whether they have any measurable benefits. The best of the three techniques studied will then form the basis for a long term early intervention study.

OBJECTIVES.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
5 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Child must have neuromuscular disease (of any diagnostic type)
  • Child and family must be enrolled in the NMD clinic at Children's hospital
  • Child must be old enough and cognitively able to perform lung function tests(usually about 5 to 6 years old)

排除标准

  • Child or guardian refuses consent for the study
  • Child has a tracheostomy
  • Child is too young or cognitively unable to perform lung function tests
  • Child has a facial asymmetry that prevents a good seal with the mask

研究组 & 干预措施

Respiratoy Therapy Devices

Experimental

Non-Invasive Bipap Ventilator, Mechanical Insufflator-Exsufflator, and High Frequency Percussive Oscillator are the three respiratory therapy devices that all participants will be using in a random order, in three consecutive days, one device per day.

干预措施: High frequency percussive oscillator (Device)

Respiratoy Therapy Devices

Experimental

Non-Invasive Bipap Ventilator, Mechanical Insufflator-Exsufflator, and High Frequency Percussive Oscillator are the three respiratory therapy devices that all participants will be using in a random order, in three consecutive days, one device per day.

干预措施: Non-invasive bipap ventilator (Device)

Respiratoy Therapy Devices

Experimental

Non-Invasive Bipap Ventilator, Mechanical Insufflator-Exsufflator, and High Frequency Percussive Oscillator are the three respiratory therapy devices that all participants will be using in a random order, in three consecutive days, one device per day.

干预措施: Mechanical insufflator-exsufflator (Device)

结局指标

主要结局

Muscle Strength

时间窗: Therapy effect assessed for 2hrs post treatment

Assessed by measuring maximal inspiratory pressure (MIP) and maximal expiratory pressures (MEP). These are obtained by inhaling and exhaling maximally through a manometer.

Cough Expiratory Flows

时间窗: Therapy effect assessed for 2hrs post treatment

Cough flows needed for adequate clearance of airway secretions. This study will measure peak expiatory flow (PEF) for which normal values are easily accessible. The two measures are comparable in clinical use (8).

Lung Volume

时间窗: Therapy effect assessed for 2hrs post treatment

Assessed by measuring vital capacity (FVC). This is a widely used test that measures effective lung volume. There are well established pediatric predictive values for FVC.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Seear

Principle Investigator

University of British Columbia

研究点 (2)

Loading locations...

相似试验

Methods to Improve Expiratory Cough Flow and Lung... | 临床试验